19-4685723-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139159.5(DPP9):c.1934G>A(p.Arg645His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139159.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151876Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247914Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134880
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461346Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726930
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151876Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74146
ClinVar
Submissions by phenotype
Hatipoglu immunodeficiency syndrome Uncertain:1
The DPP9 c.1934G>A (p.Arg645His) change has a maximum subpopulation frequency of 0.013% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL predicts a benign effect on protein function, and to our knowledge, functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with Hatipaglu immunodeficiency syndrome. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at